Table 4. The odds ratios for developing new-onset DM, metabolic syndrome, dyslipidemia, or hypertension within the four-year period adjusting for age, gender, BMI, FPG, and HOMA-IR.
| DM |
Metabolic syndrome |
Dyslipidemia |
Hypertension |
|||||
|---|---|---|---|---|---|---|---|---|
| Odds ratio | p-value | Odds ratio | p-value | Odds ratio | p-value | Odds ratio | p-value | |
| Ile | 1.41 (1.12–1.76) | 0.003 | 1.30 (1.09–1.55) | 0.004 | 1.42 (1.22–1.64) | <.0001 | 1.01 (0.88–1.17) | 0.838 |
| Leu | 1.52 (1.20–1.93) | 0.001 | 1.34 (1.12–1.61) | 0.002 | 1.38 (1.19–1.61) | <.0001 | 0.97 (0.83–1.12) | 0.653 |
| Val | 1.24 (0.99–1.55) | 0.056 | 1.13 (0.94–1.34) | 0.191 | 1.21 (1.05–1.39) | 0.007 | 0.94 (0.82–1.08) | 0.388 |
| Tyr | 1.23 (1.01–1.49) | 0.039 | 1.26 (1.08–1.47) | 0.003 | 1.15 (1.02–1.29) | 0.024 | 1.01 (0.89–1.14) | 0.893 |
| Phe | 1.30 (1.09–1.55) | 0.004 | 1.08 (0.93–1.24) | 0.326 | 1.07 (0.95–1.20) | 0.289 | 0.99 (0.88–1.12) | 0.908 |
| Ala | 1.03 (0.84–1.25) | 0.796 | 1.19 (1.02–1.38) | 0.028 | 1.35 (1.20–1.51) | <.0001 | 1.05 (0.93–1.19) | 0.395 |
| Pro | 1.09 (0.91–1.29) | 0.333 | 1.10 (0.95–1.27) | 0.199 | 1.13 (1.01–1.27) | 0.026 | 0.98 (0.87–1.11) | 0.798 |
| Met | 1.18 (0.98–1.41) | 0.079 | 1.07 (0.92–1.23) | 0.385 | 1.02 (0.91–1.15) | 0.707 | 1.00 (0.89–1.13) | 0.977 |
| Ser | 1.03 (0.85–1.25) | 0.759 | 0.85 (0.72–0.99) | 0.039 | 0.80 (0.72–0.90) | 0.0001 | 0.93 (0.83–1.04) | 0.197 |
| Gly | 1.03 (0.82–1.27) | 0.805 | 0.83 (0.67–1.01) | 0.071 | 0.85 (0.75–0.96) | 0.009 | 0.95 (0.84–1.08) | 0.464 |
| PFAA index 1 | 1.31 (1.02–1.69) | 0.036 | 1.59 (1.29–1.96) | <.0001 | 1.72 (1.47–2.02) | <.0001 | 1.07 (0.91–1.25) | 0.397 |
| PFAA index 2 | 1.39 (1.12–1.74) | 0.003 | 1.36 (1.14–1.63) | 0.001 | 1.47 (1.28–1.69) | <.0001 | 1.03 (0.90–1.19) | 0.641 |
Values are odds ratios (95% confidence intervals) as a continuous variable per SD increment for developing metabolic syndrome, DM, dyslipidemia, or hypertension from logistic regressions. Significant odds ratios are highlighted in bold type.